Product Information
COLESEVELAM 625 MG TABLET is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.3117 per EA under NDC 68382061928. Its NADAC has been published 289 times since Dec 25, 2019.
FDA first approved this application on Oct 7, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
625 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
68382061928
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
6/18/2025
Active Ingredients
COLESEVELAM HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA207765FDA Approved
10/7/2019
TE Code
AB
On Market Since
10/11/2019
Pharmacological Classes
Price Statistics
The NADAC for COLESEVELAM 625 MG TABLET has been published 289 times since Dec 25, 2019, and over the history we have for it it has declined 63.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3117 per EA |
|---|---|
| All-time high | $0.9857 (Feb 12, 2020) |
| All-time low | $0.1763 (Jul 17, 2024) |
| Median price | $0.4032 |
| Average price | $0.4143 |
| Largest weekly change | +56.2% (May 17, 2023) |
| Weeks tracked | 289 |
| Tracking since | Dec 25, 2019 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
+17.1%
5Y
-35.7%
All
-63.1%
Last surveyed Jul 2, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Colesevelam market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of COLESEVELAM 625 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for COLESEVELAM 625 MG TABLET, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.3117 per EA (NDC 68382061928), effective Jul 2, 2025.
How has the price of COLESEVELAM 625 MG TABLET changed over time?
Over the history we have for it, the NADAC for COLESEVELAM 625 MG TABLET has declined 63.1%. It has been tracked across 289 weekly CMS publications since Dec 25, 2019.
What are the highest and lowest recorded NADAC prices for COLESEVELAM 625 MG TABLET?
Since Dec 25, 2019, the NADAC for COLESEVELAM 625 MG TABLET has ranged from a low of $0.1763 (Jul 17, 2024) to a high of $0.9857 (Feb 12, 2020), with a median of $0.4032 per EA.
Are there cheaper alternatives to COLESEVELAM 625 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of COLESEVELAM 625 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures COLESEVELAM 625 MG TABLET?
COLESEVELAM 625 MG TABLET (NDC 68382061928) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.